Page last updated: 2024-11-07

prednisone and Epstein-Barr Virus Infections

prednisone has been researched along with Epstein-Barr Virus Infections in 122 studies

Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.

Epstein-Barr Virus Infections: Infection with human herpesvirus 4 (HERPESVIRUS 4, HUMAN); which may facilitate the development of various lymphoproliferative disorders. These include BURKITT LYMPHOMA (African type), INFECTIOUS MONONUCLEOSIS, and oral hairy leukoplakia (LEUKOPLAKIA, HAIRY).

Research Excerpts

ExcerptRelevanceReference
"Other iatrogenic immunodeficiency-associated lymphoproliferative disorders induced by immunosuppressive drugs, such as methotrexate (MTX-LPD), exhibit numerous pathological findings."7.96Methotrexate-associated lymphoproliferative disorder demonstrating composite lymphoma of EBV-negative diffuse large B-cell lymphoma and EBV-positive mucocutaneous ulcer. ( Carreras, J; Kikuti, YY; Kondo, Y; Moriya, K; Nakamura, N; Shiraiwa, S, 2020)
"We report an extremely rare case of massive methotrexate-associated lymphoproliferative disorder (MTX-LPD) arising in the retromolar triangle and lung of a patient with rheumatoid arthritis."7.80Methotrexate-associated lymphoproliferative disorder arising in the retromolar triangle and lung of a patient with rheumatoid arthritis. ( Harada, H; Ishii, Y; Kudoh, M; Matsumoto, K; Omura, K; Sato, Y, 2014)
"Patients with angioimmunoblastic T-cell lymphoma (AITL) are treated with cyclophosphamide, doxorubicin, vincristine and prednisone with or without etoposide (CHO(E)P)."4.12Impact of rituximab on treatment outcomes of patients with angioimmunoblastic T-cell lymphoma; a population-based analysis. ( Böhmer, L; Brink, M; Diepstra, A; Huls, GA; Jansen, PM; Kersten, MJ; Meeuwes, FO; Mutsaers, PGNJ; Nijland, M; Oostvogels, R; Plattel, WJ; Snijders, TJF; van der Poel, MWM; Vermaat, JSP; Visser, O; Woei-A-Jin, S; Wondergem, M, 2022)
"Other iatrogenic immunodeficiency-associated lymphoproliferative disorders induced by immunosuppressive drugs, such as methotrexate (MTX-LPD), exhibit numerous pathological findings."3.96Methotrexate-associated lymphoproliferative disorder demonstrating composite lymphoma of EBV-negative diffuse large B-cell lymphoma and EBV-positive mucocutaneous ulcer. ( Carreras, J; Kikuti, YY; Kondo, Y; Moriya, K; Nakamura, N; Shiraiwa, S, 2020)
"Determine the frequency and prognostic value of circulating Epstein-Barr virus (EBV) DNA copy number in angioimmunoblastic T-cell lymphoma (AITL) patients who were treated with dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide and doxorubicin (DA-EPOCH) regimens."3.91The Prognostic Role of Circulating Epstein-Barr Virus DNA Copy Number in Angioimmunoblastic T-Cell Lymphoma Treated with Dose-Adjusted EPOCH. ( Fan, L; Li, JY; Li, W; Liang, JH; Lu, L; Xu, W; Zhu, HY, 2019)
" The fourth month of induction therapy with cyclophosphamide and methylprednisone she presented with dyspnea and respiratory failure."3.88[EBV-ASSOCIATED PNEUMONIA IN PATIENT WITH GRANULOMATOSIS WITH POLYANGIITIS (GPA) IN IMMUNOSOPPRESSIVE THERAPY TREATED WITH ACICLOVIR]. ( Boscutti, G; Bregant, C; Carraro, M; Di Maso, V; Ermacora, E; Lorenzon, E; Mongera, N; Pian, M; Savi, U, 2018)
"We report an extremely rare case of massive methotrexate-associated lymphoproliferative disorder (MTX-LPD) arising in the retromolar triangle and lung of a patient with rheumatoid arthritis."3.80Methotrexate-associated lymphoproliferative disorder arising in the retromolar triangle and lung of a patient with rheumatoid arthritis. ( Harada, H; Ishii, Y; Kudoh, M; Matsumoto, K; Omura, K; Sato, Y, 2014)
"Immunodeficiency-related lymphoproliferative disorders (IR-LPD) may occur in the setting of immunosuppressive therapy with methotrexate and TNF-α antagonists."3.77Transient iatrogenic immunodeficiency-related B-cell lymphoproliferative disorder of the skin in a patient with mycosis fungoides/Sézary syndrome. ( Curry, JL; Diwan, AH; Duvic, M; Jones, DM; Prieto, VG; Vega, F, 2011)
"The shocking fact was that re-biopsy of lymphadenopathy revealed peripheral T-cell lymphoma (PTCL) and angioimmunoblastic T-cell lymphoma (AITL)."3.01Composite B-cell and T-cell lymphomas: clinical, pathological, and molecular features of three cases and literature review. ( Chen, B; Chen, P; Huang, F; Jin, X; Li, J; Liang, Y; Liu, H; Xiao, X; Yuan, X, 2023)
"We effectively treated 2 patients with panniculitis-associated HPS with ruxolitinib."2.82[Ruxolitinib as an effective treatment for panniculitis associated hemophagocytic syndrome: A report of 2 cases and literature review]. ( Chen, C; Gan, YZ; Jia, Y; Jin, YB; Li, C; Li, GM, 2022)
"Also, both the lymphoma and colon cancer stained positive for vascular endothelial growth factor (VEGF)."2.52[RS3PE syndrome associated with senile Epstein-Barr virus-positive diffuse large B cell lymphoma of a patient with colon cancer]. ( Fujii, S; Fujita, M; Iyama, S; Kanari, Y; Kato, J; Kuroda, H; Maeda, M; Nakano, T; Sakamoto, H; Shimoyama, S; Usami, M; Yamada, M; Yoshida, M, 2015)
"EBV-associated lymphomas are well characterized in patients with known defects in cellular immunity as occurs post-transplantation or HIV/AIDS but are increasingly recognized in patients without overt immunodeficiencies."2.48EBV-associated lymphomas in adults. ( Roschewski, M; Wilson, WH, 2012)
"A patient who developed Hodgkin's disease after an 11-year remission of marginal zone B-cell (MZB) lymphoma (low grade B-cell lymphoma of mucosa-associated lymphoid tissue type) is presented."2.40Hodgkin's disease following extranodal marginal zone B-cell lymphoma in remission. ( Hara, K; Shimizu, K; Yatabe, Y, 1999)
"In the largest adult case series in Burkitt-PTLD to date, sequential immunochemotherapy with rituximab followed by standard CHOP or R-CHOP was a both safe and effective treatment."1.38Burkitt post-transplantation lymphoma in adult solid organ transplant recipients: sequential immunochemotherapy with rituximab (R) followed by cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or R-CHOP is safe and effective in an analysis ( Anagnostopoulos, I; Atta, J; Gärtner, B; Lehmkuhl, H; Lenze, D; Neuhaus, R; Oertel, S; Planker, M; Reinke, P; Riess, H; Trappe, RU; Zimmermann, H, 2012)
"A 53-year-old man with systemic lupus erythematosus who was receiving chronic low-dose prednisone treatment developed proptosis of the right eye."1.35Third cranial nerve palsy caused by intracranial extension of a sino-orbital natural killer T-cell lymphoma. ( Chen, CS; Eberhart, C; Lane, A; Miller, NR, 2008)
"The occurrence rates of peripheral leukocytosis and hepatosplenomegaly were significantly higher in the patients with EBV infection than in the patients without EBV infection (P <0."1.34[Infection status and clinical significance of Epstein-Barr virus in pediatric leukemia---a report of 35 cases]. ( Lu, Y; Lu, ZH; Pang, XY; Sui, AH; Sun, LR, 2007)
"Plasmablastic lymphoma is an AIDS related lymphoma that continues to have a poor prognosis despite significant advances in the management of HIV and lymphoproliferative diseases."1.34AIDS-related plasmablastic lymphoma of the oral cavity associated with an IGH/MYC translocation--treatment with autologous stem-cell transplantation in a patient with severe haemophilia-A. ( Campbell, LJ; Dawson, MA; McLean, C; Oei, P; Schwarer, AP; Shortt, J; Street, AM; Wright, E, 2007)
" EBV-related polymorphic PTLD was diagnosed and treated with discontinuation of cyclosporine, reduction in prednisone dosage and administration of EBV-specific cytotoxic T lymphocytes."1.34Conjunctival posttransplantation lymphoproliferative disorder. ( Irshad, FA; Onciu, MM; Walton, RC; Wilson, TD, 2007)
"Two of the patients died of disease progression."1.33Epstein-Barr virus involvement is a predictive factor for the resistance to chemoradiotherapy of gastric diffuse large B-cell lymphoma. ( Ishikura, S; Kitadai, Y; Kobayashi, Y; Matsuno, Y; Mera, K; Nakamura, S; Ochiai, A; Oda, I; Ohtsu, A; Suzumiya, J; Tobinai, K; Yokoi, T; Yoshino, T, 2006)
"We describe a case of Hodgkin lymphoma developing in a 9-year-old girl with polyarticular, rheumatoid factor-positive juvenile idiopathic arthritis treated with methotrexate (MTX), prednisone, and naproxen for 5 years."1.33Epstein-Barr virus associated Hodgkin lymphoma in a 9-year-old girl receiving long-term methotrexate therapy for juvenile idiopathic arthritis. ( Abukawa, D; Ichinohazama, R; Imaizumi, M; Nakano, K; Sato, A; Takeyama, J, 2006)

Research

Studies (122)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (3.28)18.2507
2000's42 (34.43)29.6817
2010's61 (50.00)24.3611
2020's15 (12.30)2.80

Authors

AuthorsStudies
Morin, JA1
Gooch, CR1
Stowell, JT1
Mallea, JM1
Jiang, L1
Thomas, M1
Meeuwes, FO1
Brink, M1
van der Poel, MWM1
Kersten, MJ1
Wondergem, M1
Mutsaers, PGNJ1
Böhmer, L1
Woei-A-Jin, S1
Visser, O1
Oostvogels, R1
Jansen, PM1
Diepstra, A1
Snijders, TJF1
Plattel, WJ1
Huls, GA1
Vermaat, JSP1
Nijland, M1
Miyashiro, D1
Nico, MMS1
Ang, PL1
Coelho Siqueira, SA1
Pereira, J1
Sanches, JA1
Lourenço, SV1
Li, GM1
Jin, YB1
Gan, YZ1
Chen, C1
Jia, Y1
Li, C1
Jin, X1
Liu, H4
Li, J2
Xiao, X1
Yuan, X1
Chen, P1
Chen, B1
Liang, Y1
Huang, F1
Poon, F1
Ieremia, E1
Collins, G1
Matin, RN1
Nakayama, S1
Morita, Y1
Espinoza, JL1
Rai, S1
Taniguchi, Y1
Taniguchi, T1
Miyake, Y1
Tanaka, H1
Ashida, T1
Matsumura, I1
Yamaguchi, K1
Kubota, Y1
Kishimori, C1
Ohno, H1
Kidoguchi, K1
Kizuka-Sano, H1
Nishioka, A1
Katsuya, H1
Ando, T1
Kimura, S2
Moriya, K1
Kikuti, YY2
Carreras, J2
Kondo, Y1
Shiraiwa, S1
Nakamura, N2
Yoon, SE1
Kim, SJ2
Yoon, DH1
Koh, Y1
Mun, YC1
Do, YR1
Choi, YS1
Yang, DH1
Kim, MK1
Lee, GW1
Suh, C1
Ko, YH2
Kim, WS2
Yasunaga, M1
Yasuda, Y1
Honda, A1
Maki, H1
Toyama, K1
Masamoto, Y1
Bujo, C1
Amiya, E1
Hatano, M1
Ono, M1
Komuro, I1
Kurokawa, M1
Wang, J3
Zhang, R1
Cabrera Muras, A1
Carmona-Abellán, MM1
Collía Fernández, A1
Uterga Valiente, JM1
Antón Méndez, L1
García-Moncó, JC1
Mouchel, PL1
Syrykh, C1
Laurent, C1
Tavitian, S1
Gauthier, M1
Ke, YL1
Hsiao, HH1
Cho, SF1
Wu, CC1
Sprangers, B1
Riella, LV1
Dierickx, D2
Li, Z1
Wang, Y2
Zhang, J2
Wang, Z2
Lamos, C1
Dippel, E1
Tomoka, T1
Powers, E1
van der Gronde, T1
Amuquandoh, A1
Dhungel, BM1
Kampani, C1
Kamiza, S1
Montgomery, ND1
Fedoriw, Y1
Gopal, S1
Drago, F1
Merlo, G1
Cozzani, E1
Parodi, A1
Liang, JH1
Lu, L1
Zhu, HY1
Li, W1
Fan, L1
Li, JY1
Xu, W1
Zan, Y1
Chen, L1
Mongera, N1
Di Maso, V1
Ermacora, E1
Carraro, M1
Bregant, C1
Pian, M1
Savi, U1
Lorenzon, E1
Boscutti, G1
Maas, C1
Lüftinger, R1
Krois, W1
Matthes-Martin, S1
Bayer, G1
Boztug, K1
Metzelder, M1
Wass, M1
Bauer, M1
Pfannes, R1
Lorenz, K1
Odparlik, A1
Müller, LP1
Wickenhauser, C1
Menditto, VG1
Guerrieri, G1
Riccomi, F1
Nobili, L1
García-Cadenas, I1
Yáñez, L1
Jarque, I1
Martino, R1
Pérez-Simón, JA1
Valcárcel, D1
Sanz, J1
Bermúdez, A1
Muñoz, C1
Calderón-Cabrera, C1
García, E1
Alonso, L1
Suárez-Lledó, M1
González Vicent, M1
Heras, I1
Viguria, MC1
Batlle, M1
Vázquez, L1
López, J1
Solano, C1
Lee, H1
Shin, H1
Kim, NY1
Park, HS1
Park, J1
Yamaguchi, J1
Fujino, T1
Isa, R1
Nishiyama, D1
Kuwahara-Ota, S1
Kawaji, Y1
Tsukamoto, T1
Chinen, Y1
Shimura, Y1
Kobayashi, T1
Horiike, S1
Kohno, K1
Nakamura, S2
Kuroda, J1
Li, WS1
Xie, JL1
Zhang, M1
Zhou, XG1
Lee, E1
Kim, TM1
Lim, Y1
Jeon, YK1
Go, H1
Kim, CW1
Heo, DS1
Ozsan, N1
Cagirgan, S1
Saydam, G1
Gunes, A1
Hekimgil, M1
Naidu, A1
Kessler, HP1
Pavelka, MA1
Zimmermann, H2
Trappe, RU2
Ok, CY1
Li, L3
Xu-Monette, ZY1
Visco, C1
Tzankov, A1
Manyam, GC1
Montes-Moreno, S1
Dybkaer, K1
Dybaer, K1
Chiu, A1
Orazi, A1
Zu, Y1
Bhagat, G1
Chen, J1
Richards, KL1
Hsi, ED1
Choi, WW1
van Krieken, JH1
Huh, J1
Ai, W1
Ponzoni, M1
Ferreri, AJ1
Farnen, JP1
Møller, MB1
Bueso-Ramos, CE1
Miranda, RN1
Winter, JN1
Piris, MA1
Medeiros, LJ1
Young, KH1
Tapan, U1
Pestana, JB1
Lee, JC1
Lerner, A1
Kudoh, M1
Harada, H1
Matsumoto, K1
Sato, Y1
Omura, K1
Ishii, Y1
Sato, A2
Kojima, M1
Ohmachi, K1
Numata, H1
Ohgiya, D1
Tazume, K1
Amaki, J1
Moriuchi, M1
Miyamoto, M1
Aoyama, Y1
Kawai, H1
Ichiki, A1
Hara, R1
Kawada, H1
Ogawa, Y2
Ando, K1
Shah, NN1
Harrison, N1
Stonecypher, M1
Frank, D1
Amorosa, V1
Svoboda, J1
Kuriyama, T1
Kawano, N1
Yamashita, K1
Ueda, A1
Ferreiro, JF1
Morscio, J1
Marcelis, L1
Verhoef, G1
Vandenberghe, P1
Tousseyn, T1
Wlodarska, I1
Santalla-Martínez, M1
García-Quiroga, H1
Navarro-Menéndez, I1
Meister, MT1
Voss, S1
Schwabe, D1
Yoshimori, M2
Takada, H1
Imadome, K1
Kurata, M1
Yamamoto, K1
Koyama, T2
Shimizu, N1
Fujiwara, S2
Miura, O2
Arai, A2
Ikebe, T1
Sasaki, H1
Saburi, Y1
Ogata, M1
Tisi, MC1
Cupelli, E1
Santangelo, R1
Maiolo, E1
Alma, E1
Giachelia, M1
Martini, M1
Bellesi, S1
D'Alò, F1
Voso, MT1
Pompili, M1
Leone, G1
Larocca, LM1
Hohaus, S1
Shimoyama, S1
Kuroda, H1
Yoshida, M1
Usami, M1
Sakamoto, H1
Yamada, M2
Fujii, S1
Maeda, M1
Fujita, M1
Nakano, T1
Kanari, Y1
Iyama, S1
Kato, J1
Koizumi, Y1
Uehira, T1
Ota, Y1
Yajima, K1
Tanuma, J1
Yotsumoto, M1
Hagiwara, S1
Ikegaya, S1
Watanabe, D1
Minamiguchi, H1
Hodohara, K1
Murotani, K1
Mikamo, H1
Wada, H1
Ajisawa, A1
Shirasaka, T1
Nagai, H1
Kodama, Y1
Hishima, T1
Mochizuki, M1
Katano, H2
Okada, S1
Wu, L1
Lai, W1
Hong, JY1
Ryu, KJ1
Park, C1
Hong, M1
Wang, JW1
Chen, JY1
Lu, C1
Tang, X1
Ziarkiewicz-Wróblewska, B1
Górnicka, B1
Gierej, B1
Suleiman, W1
Nowacka-Cieciura, E1
Durlik, M1
Bogdańska, M1
Wasiutyński, A1
Pileri, SA1
Henry, DD1
Hunger, SP1
Braylan, RC1
Dharnidharka, VR1
Johnston, A1
Salles, G1
Espinouse, D1
Felman, P1
André, P1
Berger, F1
Coiffier, B1
Dubal, DB1
Mueller, S1
Ruben, BS1
Engstrom, JW1
Josephson, SA1
Bosman, G1
Langemeijer, SM1
Hebeda, KM1
Raemaekers, JM1
Pickkers, P1
van der Velden, WJ1
Curry, JL1
Prieto, VG1
Jones, DM1
Vega, F1
Duvic, M1
Diwan, AH1
Kost Al, M1
Kost Alová, M1
Belada, D1
Laco, J1
Skugor, ND1
Perić, Z1
Vrhovac, R1
Radić-Kristo, D1
Kardum-Skelin, I1
Jaksić, B1
Machado, AS1
Da Silva Robaina, MC1
Magalhães De Rezende, LM1
Apa, AG1
Amoêdo, ND1
Bacchi, CE1
Klumb, CE1
Jones, K1
Gandhi, MK1
Ninan, MJ1
Datta, YH1
Pinho-Apezzato, ML1
Tannuri, U1
Tannuri, AC1
Mello, ES1
Lima, F1
Gibelli, NE1
Santos, MM1
Ayoub, AA1
Maksoud-Filho, JG1
Velhote, MC1
Silva, MM1
Andrade, WC1
Miyatani, HT1
Adams, B1
Lazarchick, J1
Medina, AM1
Willner, IR1
Neville, B1
Murphy, E1
Stuart, R1
Costa, LJ1
Ichikawa, S1
Fukuhara, N1
Yamamoto, J1
Suzuki, M1
Nakajima, S1
Okitsu, Y1
Kohata, K1
Onishi, Y1
Ishizawa, K1
Kameoka, J1
Harigae, H1
Zhang, F2
Liu, YH2
Zhuang, HG2
Luo, XL2
Xu, J1
Rushing, EC1
Hoschar, AP1
McDonnell, JK1
Billings, SD1
Cooles, FA1
Jackson, GH1
Menon, G1
Isaacs, JD1
Imadome, KI1
Watanabe, Y1
Kawaguchi, T1
Nakaseko, C1
Caudron, A1
Bouaziz, JD1
Battistella, M1
Sibon, D1
Lok, C1
Leclech, C1
Ortonne, N1
Molinier-Frenkel, V1
Bagot, M1
Law, MF1
Poon, WL1
Ng, KS1
Chan, HN1
Lai, HK1
Ha, CY1
Ng, C1
Yeung, YM1
Yip, SF1
Miyagi, S1
Sekiguchi, S1
Kawagishi, N1
Akamatsu, Y1
Satoh, K1
Takeda, I1
Fukushima, D1
Kobayashi, Y2
Tokodai, K1
Fujimori, K1
Satomi, S1
Xu, FP1
Luo, DL1
Du, X1
Li, WY1
Chen, Q1
Zoroquiain, P1
González, S1
Molgó, M1
Rodríguez, A1
Valbuena, JR1
Bouguila, J1
Tej, A1
Hasni, I1
Essoussi, AS1
Boughamoura, L1
Reinke, P1
Neuhaus, R1
Lehmkuhl, H1
Oertel, S1
Atta, J1
Planker, M1
Gärtner, B1
Lenze, D1
Anagnostopoulos, I1
Riess, H1
Roschewski, M1
Wilson, WH1
Santos, M1
Nogueira, L1
Talahri, C1
Massone, C1
Cerroni, L1
Mira, MT1
Talhari, S1
Wang, E1
Papavassiliou, P1
Sebastian, S1
Gross, TG2
Orjuela, MA1
Perkins, SL1
Park, JR2
Lynch, JC2
Cairo, MS1
Smith, LM1
Hayashi, RJ1
Meckenstock, R1
Therby, A1
Gibault-Genty, G1
Khau, D1
Monnier, S1
Greder-Belan, A1
Kanakry, JA1
Li, H1
Gellert, LL1
Lemas, MV1
Hsieh, WS1
Hong, F1
Tan, KL1
Gascoyne, RD1
Gordon, LI1
Fisher, RI1
Bartlett, NL1
Stiff, P1
Cheson, BD1
Advani, R1
Miller, TP1
Kahl, BS1
Horning, SJ1
Ambinder, RF1
Du, MQ1
Diss, TC1
Ye, H1
Hamoudi, RA1
Cabeçadas, J1
Dong, HY1
Harris, NL1
Chan, JK1
Rees, JW1
Dogan, A1
Isaacson, PG1
Watts, RG1
Hilliard, LM1
Berkow, RL1
Bunnapradist, S1
Vo, A1
Toyoda, M1
Alsabeh, R1
Lockhart, C1
Puliyanda, D1
Jordan, SC1
Zamkoff, KW1
Bergman, S1
Beaty, MW1
Buss, DH1
Pettenati, MJ1
Hurd, DD1
Adiga, GU1
Abebe, L1
Wiernik, PH1
Nobili, V1
Comparcola, D1
Sartorelli, MR1
Devito, R1
Marcellini, M1
Navarro, JT1
Ribera, JM2
Juncà, J1
Millá, F1
Hayashi, K1
Joko, H1
Koirala, TR1
Onoda, S1
Jin, ZS1
Munemasa, M1
Ohara, N1
Oda, W1
Tanaka, T1
Oka, T1
Kondo, E1
Yoshino, T2
Takahashi, K1
Akagi, T1
Xicoy, B1
Esteve, J1
Brunet, S1
Sanz, MA1
Fernández-Abellán, P1
Feliu, E1
Yamamoto, Y1
Teruya, K1
Niino, H1
Yasuoka, A1
Oka, S1
Motegi, S1
Nishizaki, Y1
Muramatsu, C1
Nakamura, H1
Kobayashi, F1
Shiozawa, H1
Kamochi, J1
Itakura, M1
Shibuya, M1
Ogawa, T1
Matsuzaki, S1
Tranchida, P1
Bayerl, M1
Voelpel, MJ1
Palutke, M1
Itälä, M1
Aho, H1
Remes, K1
Norin, S1
Kimby, E1
Ericzon, BG1
Christensson, B1
Sander, B1
Söderdahl, G1
Hägglund, H1
Bucuvalas, JC1
Greiner, TC1
Hinrich, SH1
Kaufman, SS1
Langnas, AN1
McDonald, RA1
Ryckman, FC1
Shaw, BW1
Sudan, DL1
Rao, R1
Vugman, G1
Leslie, WT1
Loew, J1
Venugopal, P1
Nishio, M1
Endo, T1
Fujimoto, K2
Sato, N2
Sakai, T1
Obara, M1
Kumano, K2
Minauchi, K1
Koike, T1
Matsuno, Y1
Ochiai, A1
Yokoi, T1
Kitadai, Y1
Suzumiya, J1
Tobinai, K1
Oda, I1
Mera, K1
Ohtsu, A1
Ishikura, S1
Snow, AL1
Vaysberg, M1
Krams, SM1
Martinez, OM1
Takeyama, J1
Nakano, K1
Abukawa, D1
Ichinohazama, R1
Imaizumi, M1
Lu, Y1
Sun, LR1
Pang, XY1
Lu, ZH1
Sui, AH1
Lee, DA1
Tatevian, N1
Herring, RA1
McClain, KL1
Dawson, MA1
Schwarer, AP1
McLean, C1
Oei, P1
Campbell, LJ1
Wright, E1
Shortt, J1
Street, AM1
Walton, RC1
Onciu, MM1
Irshad, FA1
Wilson, TD1
Nguyen, BD1
Roarke, MC1
McCullough, AE1
Snavely, NR1
Sonabend, M1
Rosen, T1
Chen, CS1
Miller, NR1
Lane, A1
Eberhart, C1
Tokuhira, M1
Iizuka, A1
Watanabe, R1
Sekiguchi, N1
Chien, CK1
Sekiguchi, Y1
Nemoto, T1
Hanzawa, K1
Tamaru, JI1
Itoyama, S1
Suzuki, H1
Takeuchi, T1
Mori, S1
Kizaki, M1
Mentzer, SJ1
Fingeroth, J1
Reilly, JJ1
Perrine, SP1
Faller, DV1
Cacciarelli, TV1
Green, M1
Jaffe, R1
Mazariegos, GV1
Jain, A1
Fung, JJ1
Reyes, J1
Shimizu, K1
Hara, K1
Yatabe, Y1
Murray, PG1
Billingham, LJ1
Hassan, HT1
Flavell, JR1
Nelson, PN1
Scott, K1
Reynolds, G1
Constandinou, CM1
Kerr, DJ1
Devey, EC1
Crocker, J1
Young, LS1
Smets, F1
Vajro, P1
Cornu, G1
Reding, R1
Otte, JB1
Sokal, E1
Koffman, BH1
Kennedy, AS1
Heyman, M1
Colonna, J1
Howell, C1
Takubo, T1
Kumura, T1
Nishiki, S1
Kinoshita, Y1
Koh, K1
Ohta, K1
Yamane, T1
Hino, M1
Kamitani, T1
Tatsumi, N1
Tsujimura, H1
Takagi, T1
Tamaru, J1
Sakai, C1
Mamzer-Bruneel, MF1
Lomé, C1
Morelon, E1
Levy, V1
Bourquelot, P1
Jacobs, F1
Gessain, A1
Mac Intyre, E1
Brousse, N1
Kreis, H1
Hermine, O1
Tirelli, U1
Vaccher, E1
Spina, M1
Carbone, A1
Merayo-Lloves, J1
Baltatzis, S1
Foster, CS1
Alvarez-Larrán, A1
Villamor, N1
Hernández-Boluda, JC1
Ferrer, A1
Camós, M1
Campo, E1
López-Guillermo, A1

Clinical Trials (6)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Phase II, Prospective, Multi-center Study of Sintilimab in Combination With R-CHOP in Patients With Treatment-naive EBV-positive DLBCL, NOS[NCT04181489]Phase 255 participants (Anticipated)Interventional2019-01-01Recruiting
L-DEP Regimen as a Salvage Therapy for Refractory Epstein Barr Virus-induced Hemophagocytic Lymphohistiocytosis[NCT02631109]Phase 3120 participants (Anticipated)Interventional2015-12-31Recruiting
Phase II Study of Cyclophosphamide, Prednisone and Rituximab (CPR) in Children, Adolescents and Young Adults With B-lymphocyte Antigen CD20 (CD20) Positive Post-Transplant Lymphoproliferative Disease (PTLD) Following Solid Organ Transplantation (SOT)[NCT00066469]Phase 255 participants (Actual)Interventional2004-04-30Completed
A Randomized Phase III Trial of ABVD Versus Stanford V (+/-) Radiation Therapy in Locally Extensive and Advanced Stage Hodgkin's Disease[NCT00003389]Phase 3854 participants (Actual)Interventional1999-06-17Completed
LINFOTARGAM: First-line Treatment With Dose-dense Chemotherapy Plus Rituximab (R-CHOP/14) and Highly Active Antiretroviral Therapy (HAART) in Patients With Diffuse Large B Cell Lymphoma (DLBCL) and Infection With the Human Immunodeficiency Virus (HIV)[NCT00466258]Phase 450 participants (Anticipated)Interventional2006-10-31Completed
A PHASE I TRIAL OF BUTYRATE AND GANCICLOVIR IN EBV-ASSOCIATED MALIGNANCIES[NCT00006340]Phase 10 participants Interventional1994-12-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Event-free Survival

Alive in continuous complete remission with functioning original allograft. The Event Free Survival (EFS) will be estimated by the Kaplan-Meier method. (NCT00066469)
Timeframe: 2 years

Interventionpercentage of participants analyzed (Number)
Cyclophosphamide, Prednisone, Rituximab71

5-year Overall Survival

Overall survival is defined as the time from randomization to death or last known alive. The 5-year survival rate is the probability a patient survives 5 years. (NCT00003389)
Timeframe: Assessed every 2 months if patient is < 1 year from study entry, every 3 months for the second year, every 4 months for the third year, every 6 months for years 4 and 5, and yearly for 5 years

InterventionProportion of patients (Number)
Arm A (ABVD)0.88
Arm B (Stanford V)0.88

Failure-free Survival at 5 Years

"Failure-free survival is defined as the time from randomization to the earlier of progression/relapse or death. The 5-year failure-free survival is the probability a patient is failure-free and survives 5 years.~Progression is defined as an increase in size of 25% of the sum of the products of the pretreatment measurements or appearance of new lesions. Significant enlargement of the liver or spleen is evidence of progression. A significant increase in size is defined as > 2.0 cm in distance between costal margin and the inferior margin of either organ.~Relapse is defined as the re-appearance of any clinical evidence of Hodgkin's disease in a patient who has had a complete response. Relapse for partial responders is defined as progressive disease relative to disease status during the partial remission." (NCT00003389)
Timeframe: Assessed every 2 months if patient is < 1 year from study entry, every 3 months for the second year, every 4 months for the third year, every 6 months for years 4 and 5

InterventionProportion of patients (Number)
Arm A (ABVD)0.74
Arm B (Stanford V)0.71

Incidence of Second Cancers

Number of patients who developed second primary cancers (NCT00003389)
Timeframe: Assessed every 2 months if patient is < 1 year from study entry, every 3 months for the second year, every 4 months for the third year, every 6 months for years 4 and 5, and yearly for 5 years

Interventionparticipants (Number)
Arm A (ABVD)15
Arm B (Stanford V)19

Reviews

18 reviews available for prednisone and Epstein-Barr Virus Infections

ArticleYear
[Ruxolitinib as an effective treatment for panniculitis associated hemophagocytic syndrome: A report of 2 cases and literature review].
    Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 2022, Dec-18, Volume: 54, Issue:6

    Topics: Aged; Anti-Bacterial Agents; Dexamethasone; Epstein-Barr Virus Infections; Etoposide; Exanthema; Fem

2022
Composite B-cell and T-cell lymphomas: clinical, pathological, and molecular features of three cases and literature review.
    Journal of Zhejiang University. Science. B, 2023, Aug-15, Volume: 24, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Epstein-Barr Virus In

2023
Composite lymphoma of cervical lymph nodes with classical Hodgkin lymphoma and diffuse large B cell lymphoma: a case report and literature review.
    Annals of palliative medicine, 2020, Volume: 9, Issue:5

    Topics: Composite Lymphoma; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Hodgkin Disease; Humans; Ly

2020
Posttransplant Lymphoproliferative Disorder Following Kidney Transplantation: A Review.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2021, Volume: 78, Issue:2

    Topics: Alleles; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Azathioprine; Calcine

2021
[Aggressive primary cutaneous B-cell lymphomas and novel EBV+ entities].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2017, Volume: 68, Issue:9

    Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols;

2017
Chronic active Epstein-Barr virus infection of T-cell type, systemic form in an African migrant: case report and review of the literature on diagnostics standards and therapeutic options.
    BMC cancer, 2018, Oct-03, Volume: 18, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Biopsy; Black People; Chronic Dis

2018
Epstein-Barr virus-positive oral ulceration simulating Hodgkin lymphoma in a patient treated with methotrexate: case report and review of the literature.
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2014, Volume: 72, Issue:4

    Topics: Aged, 80 and over; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Diagnosis,

2014
[RS3PE syndrome associated with senile Epstein-Barr virus-positive diffuse large B cell lymphoma of a patient with colon cancer].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2015, Volume: 56, Issue:11

    Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biopsy

2015
Hodgkin-like lymphoma, simulating anaplastic large cell lymphoma in the patient after renal transplantation--unusual case report and literature review.
    Polish journal of pathology : official journal of the Polish Society of Pathologists, 2008, Volume: 59, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Biomarkers, Tumor; Bone Marrow; Cy

2008
Post-transplant lymphoproliferative disorder presenting as multiple myeloma.
    American journal of hematology, 2010, Volume: 85, Issue:8

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy

2010
Two atypical cases of cutaneous gamma/delta T-cell lymphomas.
    Dermatology (Basel, Switzerland), 2011, Volume: 222, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide

2011
EBV-associated lymphomas in adults.
    Best practice & research. Clinical haematology, 2012, Volume: 25, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Epstein-Barr V

2012
Partially successful treatment of a patient with chronic lymphocytic leukemia and Hodgkin's disease: case report and literature review.
    American journal of hematology, 2003, Volume: 72, Issue:4

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bowen's Disease; Co

2003
Post-transplant Burkitt's leukemia or lymphoma. Study of five cases treated with specific intensive therapy (PETHEMA ALL-3/97 trial).
    Leukemia & lymphoma, 2003, Volume: 44, Issue:9

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cyt

2003
Reduced-intensity conditioning and blood stem cell transplantation from an HLA-identical sibling for severe aplastic anaemia: two patients with successful engraftment but a fatal post-transplant lymphoproliferative disorder in the other.
    The hematology journal : the official journal of the European Haematology Association, 2004, Volume: 5, Issue:5

    Topics: Adrenal Cortex Hormones; Anemia, Aplastic; Antilymphocyte Serum; Cyclosporine; Diabetes Mellitus, Ty

2004
Hodgkin's disease following extranodal marginal zone B-cell lymphoma in remission.
    International journal of hematology, 1999, Volume: 69, Issue:2

    Topics: Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Combined Modality

1999
Hodgkin's disease: clinical presentation and treatment.
    Cancer treatment and research, 2001, Volume: 104

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined

2001
Blastic natural killer cell leukemia/lymphoma presenting as overt leukemia.
    Clinical lymphoma, 2001, Volume: 2, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antigens, CD; Antineoplastic Combined Chemotherapy Proto

2001

Trials

7 trials available for prednisone and Epstein-Barr Virus Infections

ArticleYear
A phase II study of ibrutinib in combination with rituximab-cyclophosphamide-doxorubicin hydrochloride-vincristine sulfate-prednisone therapy in Epstein-Barr virus-positive, diffuse large B cell lymphoma (54179060LYM2003: IVORY study): results of the fina
    Annals of hematology, 2020, Volume: 99, Issue:6

    Topics: Adenine; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Case-Contro

2020
PEG-aspargase and DEP regimen combination therapy for refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Journal of hematology & oncology, 2016, 09-09, Volume: 9, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cisplatin; D

2016
Clinical impact of serum survivin positivity and tissue expression of EBV-encoded RNA in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.
    Oncotarget, 2017, Feb-21, Volume: 8, Issue:8

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cohort Studies; Cycl

2017
Low-dose chemotherapy and rituximab for posttransplant lymphoproliferative disease (PTLD): a Children's Oncology Group Report.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2012, Volume: 12, Issue:11

    Topics: Adolescent; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols;

2012
Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial.
    Blood, 2013, May-02, Volume: 121, Issue:18

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci

2013
Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Sep-20, Volume: 23, Issue:27

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Confidence Inte

2005
Effect of Epstein-Barr virus infection on response to chemotherapy and survival in Hodgkin's disease.
    Blood, 1999, Jul-15, Volume: 94, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Disease-Free Survival; England; Epstei

1999

Other Studies

97 other studies available for prednisone and Epstein-Barr Virus Infections

ArticleYear
A 71-Year-Old Man With Diffuse Waxing and Waning Multifocal Lung Lesions, Empyema, and Episodic Fevers Reveals a Rare Diagnosis.
    Chest, 2022, Volume: 161, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchoscopy; Cyclophosphamide; Doxorubicin; E

2022
Impact of rituximab on treatment outcomes of patients with angioimmunoblastic T-cell lymphoma; a population-based analysis.
    European journal of cancer (Oxford, England : 1990), 2022, Volume: 176

    Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophospha

2022
Extraordinary Case: Unique Presentation of an Aggressive Epstein-Barr Virus-Positive Mucocutaneous Ulcer.
    The American Journal of dermatopathology, 2022, Dec-01, Volume: 44, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Epstein-Barr Virus In

2022
Epstein-Barr Virus-Induced Cutaneous Diffuse Large B-Cell Lymphoma in a Patient With Angioimmunoblastic T-Cell Lymphoma.
    The American Journal of dermatopathology, 2019, Volume: 41, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Epstein-Barr Virus In

2019
Multiple cytokine-producing aggressive EBV-positive diffuse large B cell lymphoma, not otherwise specified with hemophagocytic syndrome.
    Annals of hematology, 2020, Volume: 99, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cyclophosphamide; Cytokines; Doxorubici

2020
Epstein-Barr virus-positive diffuse large B cell lymphoma, not otherwise specified, carrying a t(19;22)(q13;q11) translocation.
    Annals of hematology, 2020, Volume: 99, Issue:2

    Topics: Abnormal Karyotype; Aged; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Chromosomes

2020
Methotrexate-associated lymphoproliferative disorder demonstrating composite lymphoma of EBV-negative diffuse large B-cell lymphoma and EBV-positive mucocutaneous ulcer.
    Journal of clinical and experimental hematopathology : JCEH, 2020, Volume: 60, Issue:1

    Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Composite Lymphoma; Cyclophospham

2020
Successful treatment of EBV-related lymphoproliferative disease after heart transplantation with autologous hematopoietic stem cell transplantation despite transient heart failure associated with engraftment syndrome.
    Annals of hematology, 2021, Volume: 100, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Epstein-B

2021
Bilateral facial nerve palsy associated with COVID-19 and Epstein-Barr virus co-infection.
    European journal of neurology, 2021, Volume: 28, Issue:1

    Topics: Anti-Inflammatory Agents; COVID-19; Epstein-Barr Virus Infections; Facial Paralysis; Humans; Magneti

2021
First case of classical Hodgkin-like EBV-positive lymphoproliferative disorder under ruxolitinib therapy.
    American journal of hematology, 2021, 06-01, Volume: 96, Issue:6

    Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Deoxycytidine; DNA, Viral

2021
A tip of the iceberg: Disseminated plasmablastic lymphoma, diagnosed from a local oral lesion.
    The Kaohsiung journal of medical sciences, 2021, Volume: 37, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Biopsy

2021
Haploidentical hematopoietic stem cell transplantation for adult patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Leukemia & lymphoma, 2018, Volume: 59, Issue:1

    Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Prot

2018
Extranodal natural killer/T-cell lymphoma in Malawi: a report of three cases.
    BMC cancer, 2017, Sep-06, Volume: 17, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Biopsy; Cyclophosphamide; DNA, Vi

2017
Urticaria associated with Epstein-Barr virus reactivation.
    Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2019, Volume: 154, Issue:6

    Topics: Acyclovir; Antibodies, Viral; Antigens, Viral; Antiviral Agents; Capsid Proteins; DNA, Viral; Epstei

2019
The Prognostic Role of Circulating Epstein-Barr Virus DNA Copy Number in Angioimmunoblastic T-Cell Lymphoma Treated with Dose-Adjusted EPOCH.
    Cancer research and treatment, 2019, Volume: 51, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; DNA Copy Number Varia

2019
Hydroa vacciniforme-like cutaneous T-cell lymphoma in a child: A case report.
    Medicine, 2018, Volume: 97, Issue:15

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Diagnosis, Differential; Do

2018
[EBV-ASSOCIATED PNEUMONIA IN PATIENT WITH GRANULOMATOSIS WITH POLYANGIITIS (GPA) IN IMMUNOSOPPRESSIVE THERAPY TREATED WITH ACICLOVIR].
    Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia, 2018, Volume: 35, Issue:3

    Topics: Acyclovir; Aged; Antiviral Agents; Cyclophosphamide; Disease Susceptibility; Dyspnea; Epstein-Barr V

2018
EBV-positive B-cell lymphoma manifestation of the liver in an infant with RAG1 severe combined immunodeficiency disease.
    Pediatric blood & cancer, 2018, Volume: 65, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorub

2018
Facial palsy associated with Epstein-Barr infection in an adult patient: case report.
    Internal and emergency medicine, 2019, Volume: 14, Issue:3

    Topics: Adult; Antiviral Agents; Epstein-Barr Virus Infections; Facial Paralysis; Glucocorticoids; Herpesvir

2019
Frequency, characteristics, and outcome of PTLD after allo-SCT: A multicenter study from the Spanish group of blood and marrow transplantation (GETH).
    European journal of haematology, 2019, Volume: 102, Issue:6

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Child; Child, Prescho

2019
Diffuse Large B-Cell Lymphoma Arising within Ileal Neobladder: An Expanding Spectrum of Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation.
    Cancer research and treatment, 2019, Volume: 51, Issue:4

    Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Ep

2019
Epstein-Barr virus-associated lymphoproliferative disease during imatinib mesylate treatment for chronic myeloid leukemia.
    Haematologica, 2019, Volume: 104, Issue:8

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Epstein-Barr Vi

2019
[EBV-positive diffuse large B-cell lymphoma in young individual: report of a case].
    Zhonghua bing li xue za zhi = Chinese journal of pathology, 2013, Volume: 42, Issue:2

    Topics: Adult; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; CD3 Complex; Cyclophosphamide

2013
Histologic transformation of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Jul-01, Volume: 31, Issue:19

    Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bacteremia;

2013
Epstein-Barr virus (EBV) positive diffuse large B cell lymphoma of the elderly-experience of a single center from Turkey.
    Pathology, research and practice, 2013, Volume: 209, Issue:8

    Topics: Age Factors; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combine

2013
EBV and posttransplantation lymphoproliferative disease: what to do?
    Hematology. American Society of Hematology. Education Program, 2013, Volume: 2013

    Topics: Adult; Allografts; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Prot

2013
Prevalence and clinical implications of epstein-barr virus infection in de novo diffuse large B-cell lymphoma in Western countries.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2014, May-01, Volume: 20, Issue:9

    Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols;

2014
Epstein-Barr virus-associated diffuse large B-cell lymphoma arising in atrial myxoma: a proposal for a modified therapeutic approach.
    Leukemia & lymphoma, 2015, Volume: 56, Issue:2

    Topics: Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Epstein-Barr Virus

2015
Methotrexate-associated lymphoproliferative disorder arising in the retromolar triangle and lung of a patient with rheumatoid arthritis.
    Oral surgery, oral medicine, oral pathology and oral radiology, 2014, Volume: 118, Issue:4

    Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antirh

2014
Clinical outcome of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly in the rituximab era.
    Cancer science, 2014, Volume: 105, Issue:9

    Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclop

2014
Extracavitary primary effusion lymphoma initially presenting with hemophagocytic lymphohistocytosis.
    Clinical lymphoma, myeloma & leukemia, 2014, Volume: 14, Issue:5

    Topics: Adrenal Cortex Hormones; Adult; Anti-HIV Agents; Antibodies, Monoclonal, Murine-Derived; Antineoplas

2014
Successful treatment of Rituximab-resistant Epstein-Barr virus-associated post-transplant lymphoproliferative disorder using R-CHOP.
    Journal of clinical and experimental hematopathology : JCEH, 2014, Volume: 54, Issue:2

    Topics: Adult; Anemia, Aplastic; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherap

2014
Post-transplant molecularly defined Burkitt lymphomas are frequently MYC-negative and characterized by the 11q-gain/loss pattern.
    Haematologica, 2015, Volume: 100, Issue:7

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adolescent; Adult; Aged; Antineoplastic Combined Che

2015
Pulmonary lymphomatoid granulomatosis. A rare entity in the differential diagnosis of pulmonary nodules.
    Archivos de bronconeumologia, 2015, Volume: 51, Issue:11

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Asymptomatic Diseases; Diagnosis, Differential

2015
Treatment of EBV-associated nodular sclerosing Hodgkin lymphoma in a patient with ataxia telangiectasia with brentuximab vedotin and reduced COPP plus rituximab.
    Pediatric blood & cancer, 2015, Volume: 62, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Ataxia Telangiectasia; Brentuximab Vedotin; Cyclopho

2015
P-glycoprotein is expressed and causes resistance to chemotherapy in EBV-positive T-cell lymphoproliferative diseases.
    Cancer medicine, 2015, Volume: 4, Issue:10

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B

2015
Bilateral psoas muscle lymphoma: an unusual presentation of EBV-positive diffuse large B-cell lymphoma of the elderly.
    International journal of hematology, 2015, Volume: 102, Issue:5

    Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclop

2015
Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma.
    Leukemia & lymphoma, 2016, Volume: 57, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic C

2016
Clinical and pathological aspects of human immunodeficiency virus-associated plasmablastic lymphoma: analysis of 24 cases.
    International journal of hematology, 2016, Volume: 104, Issue:6

    Topics: Adult; Anti-Retroviral Agents; Antineoplastic Combined Chemotherapy Protocols; CD4 Lymphocyte Count;

2016
Sequential development of peripheral t-cell lymphoma post immunochemotherapy of diffuse large B cell lymphoma.
    Cancer biology & therapy, 2017, 04-03, Volume: 18, Issue:4

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cisplatin; Cytarabine; Epstein-Barr Vi

2017
Low viral load post-transplant lymphoproliferative disease localized within the tongue.
    Transplant infectious disease : an official journal of the Transplantation Society, 2008, Volume: 10, Issue:6

    Topics: Abscess; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Cecum; Child; Epstein-Barr

2008
Epstein-Barr virus-induced lymphoproliferative disorder after rituximab combined with CHOP therapy.
    Clinical lymphoma & myeloma, 2008, Volume: 8, Issue:6

    Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemo

2008
T-cell lymphoproliferative disorder following mycophenolate treatment for myasthenia gravis.
    Muscle & nerve, 2009, Volume: 39, Issue:6

    Topics: Aged; Biomarkers; Epstein-Barr Virus Infections; Female; Genitalia, Female; Gingiva; Gingivitis; Hum

2009
The role of rituximab in a case of EBV-related lymphoproliferative disease presenting with haemophagocytosis.
    The Netherlands journal of medicine, 2009, Volume: 67, Issue:8

    Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antine

2009
Transient iatrogenic immunodeficiency-related B-cell lymphoproliferative disorder of the skin in a patient with mycosis fungoides/Sézary syndrome.
    Journal of cutaneous pathology, 2011, Volume: 38, Issue:3

    Topics: Aged; Azathioprine; B-Lymphocytes; Epstein-Barr Virus Infections; Humans; Immunocompromised Host; Im

2011
Cutaneous natural killer (NK) / T-cell lymphoma: nasal type with extensive facial destruction.
    International journal of dermatology, 2009, Volume: 48, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Doxorubicin;

2009
Diffuse large B-cell lymphoma in patient after treatment of angioimmunoblastic T-cell lymphoma.
    Collegium antropologicum, 2010, Volume: 34, Issue:1

    Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemo

2010
Circulating cell-free and Epstein-Barr virus DNA in pediatric B-non-Hodgkin lymphomas.
    Leukemia & lymphoma, 2010, Volume: 51, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D

2010
Can a blood test monitor lymphoma?
    Leukemia & lymphoma, 2010, Volume: 51, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Daunorubicin; DNA, Viral; Epste

2010
Multiple clinical presentations of lymphoproliferative disorders in pediatric liver transplant recipients: a single-center experience.
    Transplantation proceedings, 2010, Volume: 42, Issue:5

    Topics: Biliary Atresia; Child; Child, Preschool; Colonic Neoplasms; Cyclosporine; Drug Therapy, Combination

2010
Iatrogenic immunodeficiency-associated lymphoproliferative disease of the Hodgkin lymphoma-like variant in a patient treated with mycophenolate mofetil for autoimmune hepatitis.
    American journal of hematology, 2010, Volume: 85, Issue:8

    Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Diagnosis, Diff

2010
Successful allogeneic hematopoietic stem cell transplantation for aggressive NK cell leukemia.
    Internal medicine (Tokyo, Japan), 2010, Volume: 49, Issue:17

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain; Combined Modality Therap

2010
[Epstein-Barr virus-positive diffuse large B-cell lymphoma following peripheral T-cell lymphoma, not otherwise specified: report of a case].
    Zhonghua bing li xue za zhi = Chinese journal of pathology, 2010, Volume: 39, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Epstein-Barr Vi

2010
Iatrogenic oral hairy leukoplakia: report of two cases.
    Journal of cutaneous pathology, 2011, Volume: 38, Issue:3

    Topics: Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Antifungal Agents; Arthritis, Rheumatoid; Clo

2011
Epstein-Barr virus-driven lymphoproliferative disorder post-CAMPATH-1H (alemtuzumab) in refractory polymyositis.
    Rheumatology (Oxford, England), 2011, Volume: 50, Issue:4

    Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Muri

2011
Clinical features of adult-onset chronic active Epstein-Barr virus infection: a retrospective analysis.
    International journal of hematology, 2011, Volume: 93, Issue:5

    Topics: Adult; Age of Onset; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; As

2011
Quantification of plasma Epstein-Barr virus DNA for assessing treatment response in a patient with plasmablastic lymphoma.
    Annals of hematology, 2012, Volume: 91, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; DNA, Viral; Doxorubicin; E

2012
Rituximab therapy and reduction of immunosuppression to rescue graft function after renal posttransplantation lymphoproliferative disorder found by macrohematuria in a pancreas and kidney transplant recipient: a case report.
    Transplantation proceedings, 2011, Volume: 43, Issue:9

    Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclo

2011
[Clinicopathological features of Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly].
    Zhonghua bing li xue za zhi = Chinese journal of pathology, 2011, Volume: 40, Issue:9

    Topics: Aged; Aged, 80 and over; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; CD79 Antige

2011
Leukocytoclastic vasculitis as early manifestation of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly.
    The American Journal of dermatopathology, 2012, Volume: 34, Issue:3

    Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclop

2012
[Epstein-Barr virus infection and acute transverse myelitis].
    Medecine et maladies infectieuses, 2012, Volume: 42, Issue:2

    Topics: Acute Disease; Adolescent; Anti-Inflammatory Agents; Diagnosis, Differential; Epstein-Barr Virus Inf

2012
Burkitt post-transplantation lymphoma in adult solid organ transplant recipients: sequential immunochemotherapy with rituximab (R) followed by cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or R-CHOP is safe and effective in an analysis
    Cancer, 2012, Oct-01, Volume: 118, Issue:19

    Topics: Adult; Aged; Algorithms; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherap

2012
Hydroa vacciniforme-like lymphoma in a patient from the Brazilian Amazon.
    International journal of dermatology, 2013, Volume: 52, Issue:5

    Topics: Acyclovir; Antimalarials; Antineoplastic Agents, Hormonal; Antiviral Agents; Brazil; Child; Chloroqu

2013
A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstei
    Pathology, research and practice, 2012, Jun-15, Volume: 208, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Epst

2012
Adult-onset Still's disease revealed by perimyocarditis and a concomitant reactivation of an EBV infection.
    BMJ case reports, 2012, Nov-19, Volume: 2012

    Topics: Adolescent; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Diagnosis, Differentia

2012
KSHV- and EBV-associated germinotropic lymphoproliferative disorder.
    Blood, 2002, Nov-01, Volume: 100, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Clone Cells; Cyclophosphamide; Doxorubicin;

2002
Tailored chemotherapy for malignant lymphoma arising in the setting of posttransplant lymphoproliferative disorder after solid organ transplantation.
    Journal of pediatric hematology/oncology, 2002, Volume: 24, Issue:8

    Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Burkitt Lymphoma; Chemotherap

2002
Posttransplantation lymphoproliferative disorder presenting as a unilateral leg mass 10 years after kidney transplantation.
    Transplantation, 2002, Dec-15, Volume: 74, Issue:11

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Epstein-Barr Vi

2002
Fatal EBV-related post-transplant lymphoproliferative disorder (LPD) after matched related donor nonmyeloablative peripheral blood progenitor cell transplant.
    Bone marrow transplantation, 2003, Volume: 31, Issue:3

    Topics: Adult; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Doxor

2003
Autoimmune hepatitis type 1 after Epstein-Barr virus infection.
    The Pediatric infectious disease journal, 2003, Volume: 22, Issue:4

    Topics: Azathioprine; Blood Chemical Analysis; Child, Preschool; Drug Therapy, Combination; Epstein-Barr Vir

2003
Anorectal lymphoma without effusion associated with human herpesvirus-8 and type 1 Epstein-Barr virus in an HIV-infected patient.
    Human pathology, 2003, Volume: 34, Issue:6

    Topics: AIDS-Related Opportunistic Infections; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasm

2003
Therapeutic trials for a rabbit model of EBV-associated Hemophagocytic Syndrome (HPS): effects of vidarabine or CHOP, and development of Herpesvirus papio (HVP)-negative lymphomas surrounded by HVP-infected lymphoproliferative disease.
    Histology and histopathology, 2003, Volume: 18, Issue:4

    Topics: Animals; Antibodies, Viral; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cell L

2003
Rapidly progressive human herpesvirus 8-associated solid anaplastic lymphoma in a patient with AIDS--associated Kaposi sarcoma.
    Leukemia & lymphoma, 2003, Volume: 44, Issue:9

    Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Pro

2003
Hemophagocytic syndrome in ileum-origin B-cell lymphoma.
    Journal of gastroenterology, 2003, Volume: 38, Issue:10

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols;

2003
Testicular ischemia due to intravascular large B-cell lymphoma: a novel presentation in an immunosuppressed individual.
    International journal of surgical pathology, 2003, Volume: 11, Issue:4

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplasti

2003
Posttransplant lymphoma--a single-center experience of 500 liver transplantations.
    Medical oncology (Northwood, London, England), 2004, Volume: 21, Issue:3

    Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antine

2004
Lymphomatoid granulomatosis treated with rituximab and chemotherapy.
    Clinical advances in hematology & oncology : H&O, 2003, Volume: 1, Issue:11

    Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antigens, Neo

2003
Persistent panhypogammaglobulinemia with selected loss of memory B cells and impaired isotype expression after rituximab therapy for post-transplant EBV-associated autoimmune hemolytic anemia.
    European journal of haematology, 2005, Volume: 75, Issue:6

    Topics: Agammaglobulinemia; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, M

2005
Epstein-Barr virus involvement is a predictive factor for the resistance to chemoradiotherapy of gastric diffuse large B-cell lymphoma.
    Cancer science, 2006, Volume: 97, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Cyclophosphamide; Disease Prog

2006
EBV B lymphoma cell lines from patients with post-transplant lymphoproliferative disease are resistant to TRAIL-induced apoptosis.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2006, Volume: 6, Issue:5 Pt 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Cell Line,

2006
Epstein-Barr virus associated Hodgkin lymphoma in a 9-year-old girl receiving long-term methotrexate therapy for juvenile idiopathic arthritis.
    Journal of pediatric hematology/oncology, 2006, Volume: 28, Issue:9

    Topics: Arthritis, Juvenile; Child; Drug Therapy, Combination; Epstein-Barr Virus Infections; Female; Herpes

2006
[Infection status and clinical significance of Epstein-Barr virus in pediatric leukemia---a report of 35 cases].
    Ai zheng = Aizheng = Chinese journal of cancer, 2007, Volume: 26, Issue:1

    Topics: Antineoplastic Agents, Hormonal; Child; Child, Preschool; DNA, Viral; Epstein-Barr Virus Infections;

2007
EBV+ lymphoproliferative disease following prolonged chemotherapy for refractory LCH.
    Pediatric blood & cancer, 2008, Volume: 50, Issue:3

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy

2008
AIDS-related plasmablastic lymphoma of the oral cavity associated with an IGH/MYC translocation--treatment with autologous stem-cell transplantation in a patient with severe haemophilia-A.
    Haematologica, 2007, Volume: 92, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretro

2007
Conjunctival posttransplantation lymphoproliferative disorder.
    American journal of ophthalmology, 2007, Volume: 143, Issue:6

    Topics: Biomarkers; Bone Marrow Transplantation; Child; Conjunctival Diseases; Cyclosporine; DNA, Viral; Eps

2007
Methotrexate-induced and Epstein-Barr virus-associated B-cell lymphoma of the spine: MR and PET/CT imaging.
    Clinical nuclear medicine, 2008, Volume: 33, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Antirheumatic Agents; Cyclophosphamide; Dermat

2008
Posttransplant Epstein-Barr virus related lymphoproliferative disorder with a primary cutaneous presentation.
    Dermatology online journal, 2007, Oct-13, Volume: 13, Issue:4

    Topics: Dose-Response Relationship, Drug; Epstein-Barr Virus Infections; Face; Humans; Immunosuppression The

2007
Third cranial nerve palsy caused by intracranial extension of a sino-orbital natural killer T-cell lymphoma.
    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 2008, Volume: 28, Issue:1

    Topics: Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Epstein-Barr

2008
Severe degenerative change of multiple organs mediated by chronic active Epstein-Barr virus infection with infected T-cell expansion.
    International journal of hematology, 2008, Volume: 87, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Autopsy; CD4-Positive T-Lymphocytes; Cyclopho

2008
Arginine butyrate-induced susceptibility to ganciclovir in an Epstein-Barr-virus-associated lymphoma.
    Blood cells, molecules & diseases, 1998, Volume: 24, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Apoptosis; Arginine; Aspergillosis

1998
Management of posttransplant lymphoproliferative disease in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy.
    Transplantation, 1998, Oct-27, Volume: 66, Issue:8

    Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Cohort Studies; Epstein-Barr Virus Infections

1998
Indications and results of chemotherapy in children with posttransplant lymphoproliferative disease after liver transplantation.
    Transplantation, 2000, Mar-15, Volume: 69, Issue:5

    Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineopl

2000
Use of radiation therapy in posttransplant lymphoproliferative disorder (PTLD) after liver transplantation.
    International journal of cancer, 2000, Apr-20, Volume: 90, Issue:2

    Topics: Algorithms; Cyclosporine; Epstein-Barr Virus Infections; Female; Graft Rejection; Hepatitis C; Human

2000
Clinical significance of simultaneous determination of serum soluble transferrin receptor, soluble Fas, soluble Fas ligand, hepatocyte growth factor and interleukin 18 levels in a patient with hemophagocytic syndrome.
    Acta haematologica, 2000, Volume: 103, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide;

2000
Involvement of the appendix in a relapsed case of primary nasal NK/T-cell lymphoma.
    Leukemia & lymphoma, 2000, Volume: 37, Issue:5-6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Appendectomy; Appendiceal Neoplasms; Appendic

2000
Durable remission after aggressive chemotherapy for very late post-kidney transplant lymphoproliferation: A report of 16 cases observed in a single center.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Nov-01, Volume: 18, Issue:21

    Topics: Adult; Antibodies, Viral; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubi

2000
Epstein-Barr virus dacryoadenitis resulting in keratoconjunctivitis sicca in a child.
    American journal of ophthalmology, 2001, Volume: 132, Issue:6

    Topics: Acyclovir; Antiviral Agents; Child; Cyclosporine; Dacryocystitis; Drug Therapy, Combination; Epstein

2001